Biogen to Present at the 25th Annual Credit Suisse Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the 25th Annual Credit Suisse Healthcare Conference. The webcast will be live on Monday, November 7, 2016 at 9:00a.m. MT, 11:00a.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation.

About BiogenThrough cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161027006225/en/

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Source: Biogen Inc.

You May Also Be Interested In

• Biogen (BIIB) PT Raised to $260 at RBC Capital, 'Deep Dive Suggests Upcoming Liti SLE Data Could Start I&I Buildout On Right Path'
• Next 1000x Crypto Presale Search: IceBull Is Live With 1250X Potential and 15 Higher Stages Ahead
• Capital Bridge Brokers LLC Announces Business Funding Network Designed to Bridge the Gap Between Businesses and Capital